Key Insights

Highlights

Treatment Research

3 treatments under study, led by Lv5fu2

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

100%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Phase 3 (1)

Trial Status

Unknown1

Clinical Trials (1)

Showing 1 of 1 trials
NCT02502370Phase 3Unknown

Phase III Trial Investigating the Potential Benefit of Adjvant Chemotherapy for Small Bowel Adenocarcinoma

Showing all 1 trials

Research Network

Common Treatments

  • Lv5fu21
  • Folfox1
  • Observation Alone1

Active Sponsors

  • Centre Hospitalier Universitaire Dijon1
  • Centre Hospitalier Universitaire De Dijon1

Related Conditions

  • Small Bowel Adenocarcinoma1

Activity Timeline